References and Notes
1a
Oare DA.
Sanner MA.
Heathcock CH.
J. Org. Chem.
1990,
55:
132
1b
Heathcock CH.
Davidson SK.
Mills SG.
Sanner MA.
J.
Org. Chem.
1992,
57:
2531
1c
Magnus P.
Mendoza JS.
Stamford A.
Ladlow M.
Willis P.
J.
Am. Chem. Chem. Soc.
1992,
114:
10232
1d
Kim G.
Chu-Moyer MY.
Danshefsky SJ.
Schulte GK.
J.
Am. Chem. Soc.
1993,
115:
30
1e
Takahata H.
Banba Y.
Mozumi M.
Yamazaki T.
Heterocycles
1986,
24:
947
1f
Takahata H.
Yamazaki T.
Heterocycles
1988,
27:
1953
1g
Hurd RN.
Delmater GT.
Chem.
Rev.
1961,
61:
45
1h
Roth HJ.
Kleemann A.
Drug Synthesis, In Pharmaceutical
Chemistry
Vol. 1:
Wiley;
New
York:
1988.
1i
Hoeg-Jensen T.
Phosphorus,
Sulfur Silicon Relat. Elem.
1996,
108:
1
2
Sherman DB.
Spatola AF.
Wire WS.
Burks TF.
Nguyen TM.-D.
Schiller PW.
Biochem.
Biophys. Res. Commun.
1982,
162:
1126
3
Albert A.
Knecht H.
Andersen E.
Hungerford V.
Schreier MH.
Papageorgiou C.
Bioorg. Med. Chem.
1988,
8:
2203
4
Jeschke P.
Harder A.
Etzel W.
dau W.
Thielking G.
Bonse G.
Linuma K.
Pest Manag.
Sci.
2001,
57:
1000
5
Cynamon MH.
Gimi R.
Gyenes F.
Sharpe CA.
Bergmann KE.
Han HJ.
Gregor LB.
Rapolu R.
Luciano G.
Welch T.
J. Med. Chem.
1995,
38:
3902
6
Renau TE.
Ludwig MS.
Drach JC.
Townsend LB.
Bioorg.
Med. Chem. Lett.
1992,
2:
1755
7
Mehanna AS.
Belani JD.
Kelley CJ.
Pallansc LA.
Med.
Chem.
2007,
3:
513
8
Suzyki Y.
Yazaki R.
Kumagai N.
Shibasaki M.
Angew. Chem. Int. Ed.
2009,
48:
5026
9a
Kindler K.
Justus Liebigs Ann. Chem.
1923,
431:
187
9b
Zbruyev OI.
Stiasni N.
Kapper CO.
J. Comb. Chem.
2003,
5:
145
9c
Wang C.-H.
Hwang F.-Y.
Horng J.-M.
Chen C.-T.
Heterocycles
1979,
12:
1191
9d
Albert A.
Ber.
Dtsch. Chem. Ges.
1915,
48:
470
9e
Taylor EC.
Zoltewicz JA.
J.
Am. Chem. Soc.
1960,
82:
2656
9f
Liboska R.
Zyka D.
Bobek M.
Synthesis
2002,
1649
9g
Benner SA.
Tetrahedron Lett.
1981,
22:
1851
9h
Benner SA.
Tetrahedron Lett.
1981,
22:
1855
9i
Shiao MJ.
Lai LL.
Ku WS.
Lin PY.
Hwu JR.
J. Org. Chem.
1993,
58:
4772
9j
Brillon D.
Synth. Commun.
1992,
22:
1397
10
Okamoto K.
Yamamoto T.
Kanbara T.
Synlett
2007,
2687
For selected articles, see:
11a
Ozturk T.
Ertas E.
Mert O.
Chem.
Rev.
2007,
107:
5210
11b
Varma RS.
Kumar D.
Org. Lett.
1999,
1:
697
11c
Curphey TJ.
J. Org. Chem.
2002,
67:
6461
12
Charette AB.
Gernon M.
J. Org. Chem.
2003,
68:
5792
13
Pathak U.
Pandey LK.
Tank R.
J.
Org. Chem.
2008,
78:
2890
14
Borthakur N.
Goswami A.
Tetrahedron Lett.
1995,
36:
6745
15
Cho D.
Ahn J.
De Castro KA.
Ahn H.
Rhee H.
Tetrahedron
2010,
66:
5583
16a
Kaboudin B.
Norouzi H.
Synthesis
2004,
2035
16b
Kaboudin B.
Elhamifar D.
Synthesis
2006,
224
16c
Kaboudin B.
Elhamifar D.
Farjadian F.
Org.
Prep. Proced. Int.
2006,
38:
412
17 The amide (5 mmol) was added to a
mixture of O,O-diethyl ammonium
phosphorodithioate salt (10 mmol, 2.03 g)¹6a and toluene
(5 mL), and the reaction mixture was stirred for 4-10 h
at reflux. After stirring for a known period (Table
[²]
), the mixture was evaporated
under reduced pressure. The resulting mixture was subjected to column
chromatography on silica gel with EtOAc-n-hexane
(1:9), and evaporation of the solvent under reduced pressure gave
pure products in 70-91% yields. All products gave
satisfactory spectral data in accord with the assigned structures
and literature reports.9-¹6,¹8-²²
Thiobenzamide (2a)
¹H
NMR (400 MHz, CDCl3): δ = 7.29 (br,
1 H, NH2), 7.43 (t, 2 H, J = 8.0
Hz), 7.54 (t, 1 H, J = 8.0
Hz), 7.89 (d, 2 H, J = 8.0
Hz), 7.90 (br, 1 H, NH2). ¹³C
NMR (100.65 MHz, CDCl3): δ = 126.9,
128.5, 132.1, 139.2, 202.2.
2-Chlorothiobenzamide
(2b)
¹H NMR (400 MHz, CDCl3): δ = 7.35
(br, 1 H, NH2), 7.28-7.48 (m, 3 H), 7.62 (d,
1 H, J = 8.0
Hz), 8.45 (br, 1 H, NH2). ¹³C
NMR (100.65 MHz, CDCl3): δ = 127.1,
128.2, 130.1, 130.2, 131.0, 140.4, 201.5.
3-Chlorothiobenzamide
(2c)
¹H NMR (400 MHz, CDCl3): δ = 7.29
(br, 1 H, NH2), 7.37 (t, 1 H, J = 8.0
Hz), 7.50 (d, 1 H, J = 8.0
Hz), 7.72 (d, 1 H, J = 8.0
Hz), 7.88 (s, 1 H), 7.92 (br, 1 H, NH2). ¹³C
NMR (100.65 MHz, CDCl3): δ = 124.8,
127.3, 131.9, 134.6, 140.8, 201.1.
N
-Phenylthiobenzamide (2d)
¹H
NMR (400 MHz, CDCl3): δ = 7.23-7.90
(m, 10 H), 9.03 (br, 1 H, NH). ¹³C
NMR (100.65 MHz, CDCl3): δ = 123.6, 126.7,
127.0, 128.7, 129.1, 131.3, 138.9, 143.3, 198.3.
N
-(2-Ethylphenyl)thiobenzamide
(2e)
¹H NMR (400 MHz, CDCl3): δ = 1.29
(t, 3 H, J = 7.6
Hz), 2.71 (q, 2 H, J = 7.6
Hz), 7.23-7.45 (m, 3 H), 7.47 (t, 2 H, J = 7.6
Hz), 7.57 (t, 2 H, J = 7.2
Hz), 7.93 (d, 2 H, J = 7.2 Hz),
8.87 (br, 1 H, NH). ¹³C NMR (100.65
MHz, CDCl3): δ = 14.4, 24.5, 126.8,
127.4, 128.5, 128.7, 129.2, 131.5, 137.0, 139.8, 142.2, 200.0.
N
-(4-Methoxyphenyl)thiobenzamide
(2f)
¹H NMR (400 MHz, CDCl3): δ = 3.88
(s, 3 H), 7.01 (d, 2 H, J = 7.2
Hz), 7.45 (t, 2 H, J = 7.6
Hz), 7.53 (t, 1 H, J = 7.2 Hz),
7.66 (d, 2 H, J = 7.2
Hz), 7.89 (d, 2 H, J = 7.2
Hz), 8.97 (br, 1 H, NH). ¹³C NMR (100.65
MHz, CDCl3): δ = 55.5, 114.2, 125.6,
126.7, 128.7, 129.2, 131.3, 131.9, 143.0, 158.2, 198.2.
N
-(4-Bromophenyl)thiobenzamide
(2g)
¹H NMR (400 MHz, CDCl3): δ = 7.40-7.65
(m, 5 H), 7.74 (d, 2 H, J = 7.2
Hz), 7.87 (d, 2 H, J = 7.2
Hz), 8.98 (br, 1 H, NH). ¹³C NMR (100.65
MHz, CDCl3): δ = 119.9, 125.1, 128.8,
129.2, 131.5, 132.2, 137.9, 198.0.
N
-Cyclohexylthiobenzamide (2h)
¹H
NMR (400 MHz, CDCl3): δ = 1.19-1.60
(m, 5 H), 1.62-1.85 (m, 3 H), 2.17-2.25 (m, 2
H), 4.48-4.61 (m, 1 H), 7.36 (t, 2 H, J = 7.6
Hz), 7.44 (t, 1 H, J = 7.2
Hz), 7.54 (br, 1 H, NH), 7.70 (d, 2 H, J = 7.2
Hz). ¹³C NMR (100.65 MHz, CDCl3): δ = 24.7,
25.5, 31.6, 55.0, 126.7, 128.4, 130.9, 142.3, 197.6.
2-Chloro-
N
-cyclohexylthiobenzamide (2i)
¹H
NMR (400 MHz, CDCl3): δ = 1.19-1.60
(m, 5 H), 1.62-1.85 (m, 3 H), 2.17-2.25 (m, 2
H), 4.48-4.62 (m, 1 H), 7.27-7.40 (m, 3 H, NH),
7.50-7.40 (m, 1 H), 7.57-7.62 (m, 1 H). ¹³C
NMR (100.65 MHz, CDCl3): δ = 24.6,
25.5, 31.3, 54.8, 127.0, 128.3, 129.9, 130.1, 130.3, 142.2, 195.5.
N,N-
Dimethylthiobenzamide
(2j)
¹H NMR (400 MHz, CDCl3): δ = 3.03
(s, 3 H), 3.47 (s, 3 H), 7.15-7.29 (m, 5 H). ¹³C
NMR (100.65 MHz, CDCl3): δ = 43.2,
44.2, 125.7, 128.3, 128.5, 143.3, 200.7.
4-Methyl-
N
,
N-
dimethylthiobenzamide
(2k)
¹H NMR (400 MHz, CDCl3): δ = 2.34
(s, 3 H), 3.16 (s, 3 H), 3.57 (s, 3 H), 7.13 (d, 2 H, J = 8.0 Hz),
7.20 (d, 2 H, J = 8.0 Hz). ¹³C
NMR (100.65 MHz, CDCl3): δ = 21.3,
43.4, 44.3, 125.9, 128.9, 138.7, 140.6, 201.4.
4-Chloro-
N
,
N-
dimethylthiobenzamide (2l)
CAS
No. 15563-46. ¹H NMR (400 MHz, CDCl3): δ = 3.19 (s,
3 H), 3.60 (s, 3 H), 7.26 (d, 2 H, J = 8.4
Hz), 7.34 (d, 2 H, J = 8.4
Hz). ¹³C NMR (100.65 MHz, CDCl3): δ = 43.3,
44.2, 127.3, 128.6, 134.6, 141.6, 199.8.
3-Methyl-
N
,
N-
dimethylthiobenzamide
(2m)
¹H NMR (400 MHz, CDCl3): δ = 2.34
(s, 3 H), 3.14 (s, 3 H), 3.57 (s, 3 H), 7.05 (d, 1 H, J = 7.6 Hz),
7.12 (d, 2 H, J = 6.0 Hz),
7.22 (d, 1 H, J = 8.0
Hz). ¹³C NMR (100.65 MHz, CDCl3): δ = 21.4,
43.2, 44.2, 122.6, 126.3, 128.2, 129.3, 138.1, 143.4, 201.4.
Thioacetamide (2n)
CAS No. 62-55-5. ¹H
NMR (400 MHz, CDCl3): δ = 3.34 (s, 3
H), 8.90-9.20 (br, 2 H, NH2). ¹³C
NMR (100.65 MHz, CDCl3): δ = 31.0,
206.1.
18
Habibi M.
Habibi MH.
Tangestaninejad S.
Fallah-Shojaie A.
Mohammadpoor-Baltork I.
Tayyari SF.
Emtiazi G.
Hamidimotlagh R.
J.
Coord. Chem.
2005,
58:
955
19
Alliger G.
Smith GEP.
Carr EL.
Stevens HP.
J.
Org. Chem.
1949,
14:
962
20
Rauf MK.
Bolte M.
Badshah A.
Acta
Crystallogr., Sect. E: Struct. Rep. Online
2009,
65:
01265
21
Hori T.
Otani Y.
Kawahata M.
Yamaguchi K.
Ohwada T.
J.
Org. Chem.
2008,
73:
9102
22
Scheibye S.
Pedersen BS.
Lawesson S.-O.
Bull.
Soc. Chim. Belg.
1978,
78:
229
23
Bagley MC.
Chapaneri K.
Glover C.
Merritt EA.
Synlett
2004,
2615